share_log

Moderna Shares Are Trading Lower After the Company's RSV Vaccine Showed 50% Efficacy.

Benzinga ·  Jun 26 23:22
Moderna Shares Are Trading Lower After the Company's RSV Vaccine Showed 50% Efficacy.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment